cro.directory
← Compare landing

Certara vs Medpace

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCertaraMedpace
SummaryCertara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Biomarker Assays
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Microbiology Services
  • Virology Services
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Device & Combination Product Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Radiopharmaceutical
Indications
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
Phases
  • Discovery
  • Preclinical (General)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical (IND-Enabling)
  • Real-World Evidence (RWE) / Registries
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
  • Full-Service Outsourcing (FSO)
Locations
  • Global network
  • Global presence, 30 countries
  • Global presence, Multiple, 30 countries, Global
  • Global presence, Multiple, 30+ countries
  • Global presence, Multiple, 30 countries, International
  • Headquarters, Radnor, Pennsylvania, United States
  • Global presence, 30 countries
  • Global presence, 30+ countries
  • Central Laboratories, Cincinnati, Ohio, United States
  • Central Laboratory, Cincinnati, Ohio, United States
  • Headquarters, Cincinnati, OH, USA
  • Dallas, Irving, TX, USA
  • Denver, Denver, CO, USA
  • Mexico City, Mexico City, Distrito Federal, Mexico
  • Leuven, Leuven, Flemish Brabant, Belgium
  • Prague, Prague, Prague, Czech Republic
  • Copenhagen, Copenhagen, Copenhagen, Denmark
  • Lyon, Lyon, Auvergne-Rhône-Alpes, France
  • Munich, Munich, Bavaria, Germany
  • Budapest, Budapest, Budapest, Hungary
  • Rehovot, Rehovot, Central, Israel
  • Milan, Milan, Lombardy, Italy
  • London, London, England, United Kingdom
  • Maastricht, Maastricht, Limburg, Netherlands
  • Rotterdam, Rotterdam, South Holland, Netherlands
  • Warsaw, Warsaw, Masovian, Poland
  • Johannesburg, Johannesburg, Gauteng, South Africa
  • Dallas, Dallas, TX, USA
  • Madrid, Madrid, Spain
  • Mexico, Mexico City, Mexico City, Mexico
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Certara alternatives · Medpace alternatives

Markdown mirror: /compare/certara/medpace.md